baber/WOPTO huggingface dataset:
Patent CS-212754-B2 (CS)
Title: Catalyst in the production of unsaturated acids
Inventor: DOLHYJ SERGE R
IPC: B01J23/30
Filed: 1974-12-27
Abstract: 1482686 Oxidation catalyst STANDARD OIL CO 17 Dec 1974 [26 Dec 1973] 54373/74 Heading B1E [Also in Division C2]  An oxidation catalyst composition for the conversion of acrolein or methacrolein to the corresponding acids consists of oxides or oxide complexes of tungsten, vanadium, molybdenum and uranium or thorium or a mixture thereof. It may further contain one or more of Fe, Co, Ni, Zn, Cn, Mg, Mn, Bi, Ti, Zr, Sn, P, alkali metal, alkaline earth metal, lanthanium or the lanthamides and may have the empirical formula where A is Fe, Co, Ni, Zn, Cu, Mg, Mn, Bi, Ti, Zr, Sn, P, an alkali metal, an alkaline earth metal, lanthanum or a lanthanide or mixture thereof; D is U and/or Th; a is 0 to 5; b, c and d are 0.1 to 10; e is 6 to 16; and x is a number to satisfy valency requirements. The composition may comprise a support, e.g. silica, alumina, zirconia, titania, silicon carbide or boron phosphate. The catalyst may be prepared by combining precursors in an aqueous slurry, evaporating to dryness and calcining. Suitably, the preparation is such as to provide molybdenum in a state partially reduced below the hexavalent. The Examples describe the formation and use of U 2 W 1À2 V 3 Mo 12 O x .
Patent CS-249532-B2 (CS)
Title: Rodenticide
Inventor: SWAINE HARR
IPC: A01N43/16
Filed: 1984-12-12
Abstract: Improved rodenticidal compositions comprise an edible carrier and a rodenticidally effective amount of an isomer of a 3-substituted-4-hydroxycoumarin capable of existing in more than one stable isomeric form characterised in that the isomer is one which when compared with any other isomer or isomers is significantly less persistently retained in the tissues of non-rodent mammalian or avian species likely to consume either rodenticidal bait formulations or poisoned rodent carcasses the compositions being substantially free of the other isomer or isomers.
Patent JP-S615847-B2 (JP)
IPC: B21H5/02
Filed: 1980-01-10
Abstract: A rack (12, 14) for burnishing toothed gears (16) is disclosed as having an elongated body of a multiple section construction that provides accentuated axial crowns to gear teeth burnished by the rack. Leading and trailing sections (36, 38) of the rack each have a tooth forming face (44) that provides the rotary support for the gear and the burnishing of the gear teeth (46) as the gear rotates between a cooperative pair of the racks. One of the toothed forming faces, preferably the trailing one, is slightly inclined with respect to the other rack section in a lateral direction along the elongated length of the body so as to provide the accentuated axial crowns on the burnished gear teeth. Both the leading and trailing rack sections are preferably mounted on a base (42) that interconnects the rack sections. One preferred embodiment has a unitary trailing rack section whose toothed forming face is inclined in a single direction, while another preferred embodiment has a trailing rack section of a two-piece construction with the toothed forming face thereof having a shallow V shape.
Patent AU-655797-B2 (AU)
Title: Process for the genetic manipulation of myxobacteria
Inventor: JAOUA SAMIR
IPC: C12N1/21
Filed: 1992-02-28
Granted: 1995-01-12
Abstract: The present invention relates to a process for the genetic manipulation of myxobacteria, preferably of myxobacteria from the Sorangium/Polyangium group, which makes possible for the first time specific application of recombinant DNA techniques to this group of organisms. The industrial implementation of this process is primarily based on the preparation of recombinant DNA molecules which, by reason of their specific construction, are able to integrate genes or DNA sequences which, where appropriate, code for novel and desirable properties, with the aid of homologous recombination at sites, which are accurately defined by reason of the homologies present, within the bacterial genome, and on the insertion thereof into the myxobacterial cell.
Patent AU-680326-B2 (AU)
Title: Device for controlling the movement of a wing
Inventor: GUTHRIE DUNCAN RICHARD
IPC: E05F3/10
Filed: 1994-12-06
Granted: 1997-07-24
Abstract: PCT No. PCT/GB94/02668 Sec. 371 Date Apr. 17, 1996 Sec. 102(e) Date Apr. 17, 1996 PCT Filed Dec. 6, 1994 PCT Pub. No. WO95/16845 PCT Pub. Date Jun. 22, 1995A door closer comprises a housing (21) in which a compression spring (23) urges a piston (22) in one direction, an operating spindle (18) in the housing defining an axis (19) about which an arm mechanism (52) connected to the housing is angularly movable to effect movement of the piston in the opposite direction. Connected between said axis (19) and the piston (22) is a linkage mechanism which provides that, in use, maximum torque is exerted on the arm mechanism at the near closed position of the door. The linkage mechanism can have a pivotal connection (27) between links (25, 26) thereof constrained to follow a continuous curve by means of a cam track (30, 31) or an additional link (48).
Patent AU-719198-B2 (AU)
Title: A device for emptying a film tube
Inventor: PAUSER HELMUT
IPC: B65B69/00
Filed: 1997-01-24
Granted: 2000-05-04
Abstract: The rigid cap (11) has a rear cylindrical flange (13) for holding one end of the bag. The front of the bag (15) is supported by a transverse wall (12) with an outlet (17). Part of the sheeting of the bag is cut by a recess (16) starting from the transverse wall and connecting with the outlet. The recess contains at least one pin (18) whose point (19) facing the bag is set back into the recess in relation to the surface of the transverse wall supporting the bag. The height of the pin is less than half the depth of the recess. The recess with a transverse wall forms a sharp edge.
Patent AU-725340-B2 (AU)
Title: Improved methods for transforming Phaffia strains, transformed Phaffia strains so obtained and recombinant DNA in said methods
Inventor: VERDOES JAN CORNELIS
IPC: C12N15/53
Filed: 1996-12-23
Granted: 2000-10-12
Abstract: The present invention provides recombinant DNA comprising a transcription promoter and a downstream sequence to be expressed, in operable linkage therewith, wherein the transcription promoter comprises a region found upstream of the open reading frame of a highly expressed  Phaffia  gene, preferably a glycolytic pathway gene, more preferably the gene coding for Glyceraldehyde-3-Phosphate Dehydrogenase. Further preferred recombinant DNAs according to the invention contain promoters of ribosomal protein encoding genes, more preferably wherein the transcription promoter comprises a region found upstream of the open reading frame encoding a protein as represented by one of the amino acid sequences depicted in any one of SEQIDNOs: 24 to 50.  According to a further aspect of the invention an isolated DNA sequence coding for an enzyme involved in the carotenoid biosynthetic pathway of  Phaffia rhodozyma  is provided, preferably wherein said enzyme has an activity selected from isopentenyl pyrophosphate isomerase activity, geranylgeranyl pyrophosphate synthase activity, phytoene synthase activity, phytoene desaturase activity and lycopene cyclase activity, still more preferably those coding for an enzyme having an amino acid sequence selected from the one represented by SEQIDNO: 13, SEQIDNO: 15, SEQIDNO: 17, SEQIDNO: 19, SEQ ID NO: 21 or SEQIDNO: 23.  Further embodiments concern vectors, transformed host organisms, methods for making proteins and/or carotenoids, such as astaxanthin, and methods for isolating highly expressed promoters from  Phaffia .
Patent AU-670402-B2 (AU)
Title: Synchronised electronic identification system
Inventor: MARSH MICHAEL JOHN CAMILLE
IPC: G06K19/07
Filed: 1995-04-19
Granted: 1996-07-11
Abstract: The invention relates to an identification system comprising an interrogator and a plurality of transponders. The interrogator includes transmitter means (30) for transmitting an interrogation signal to the transponder, receiver means (10) for receiving a response signal from the transponder, and processor means (18) for identifying the transponder from data in the response signal. Clock extraction means (12, 20, 22, 24, 26) are further provided for extracting a transponder clock signal from the response signal which is used to synchronise the modification of the interrogation signal with the response signal from the transponder. Each transponder comprises receiver means (110, 116) for receiving the interrogation signal, a transponder clock generator (114), a code generator (112), transmitter means (110), and a modulator (118) connected to the code generator, so that on receipt of the interrogation signal the transponder transmits a response signal containing data which identifies the transponder. The interrogator is adapted to detect successful reception of a response signal from any transponder, to derive a synchronisation signal from the response signal of that transponder, and to modify the interrogation signal synchronously with the response signal to indicate successful reception of the response signal. Each transponder further includes means (116) responsive to a respective modification of the interrogation signal to cease transmission of its response signal. <IMAGE>
Patent AU-746368-B2 (AU)
Title: Method for producing water-soluble or water-swellable polymerizates with a very low residual monomer content, products produced according to this method and the use thereof
Inventor: CHMELIR MIROSLAV
IPC: C09K23/52
Filed: 1998-11-13
Granted: 2002-04-18
Abstract: The invention relates to a process for producing water-soluble or water-swellable polymer products from acrylic acid and/or acrylic acid derivatives partially or completely neutralized with nitrogen compounds and with exceedingly low levels of residual monomers, which process is characterized by subsequent heating of the polymer product at temperatures of from 120 to 240° C. The polymers produced accordingly are suitable for use as flocculants, dispersants and absorbers.
Patent AU-694482-B2 (AU)
Title: Process for recovering guanidine salts
Inventor: KIESEWETTER ERWIN
IPC: B01D61/44
Filed: 1995-02-21
Granted: 1998-07-23
Abstract: PCT No. PCT/EP95/00629 Sec. 371 Date Aug. 20, 1996 Sec. 102(e) Date Aug. 20, 1996 PCT Filed Feb. 21, 1995 PCT Pub. No. WO95/22398 PCT Pub. Date Aug. 24, 1995A process for recovering guanidine salts from diluted and contaminated aqueous solutions is described, wherein the corresponding aqueous solution (diluate) is subjected to electrodialysis and the guanidine salt is concentrated on the concentrate side. The corresponding guanidine salt can thus largely be separated from all contaminants while a relatively highly concentrated product is simultaneously obtained.
Patent AU-680740-B2 (AU)
Title: Novel indole derivatives useful to treat estrogen-related neoplasms and disorders
Inventor: BITONTI ALAN J
IPC: C07D209/42
Filed: 1995-01-31
Granted: 1997-08-07
Abstract: The present invention relates to novel indole derivatives useful in down-regulating estrogen receptor expression. Also included are methods for the treatment of neoplasms or of controlling the growth of a neoplasm in a patient afflicted with a neoplastic disease, especially estrogen-dependent neoplasms such as those associated with breast, ovarian and cervical tissue. Another embodiment of the present invention is a method of prophylactically treating a patient at risk of developing a neoplastic disease state. Also provided is a method for treating autoimmune diseases. Also included are pharmaceutical compositions of the novel indole derivatives.
Patent AU-610910-B2 (AU)
Title: Improvements in and relating to magnetic resonance imaging
Inventor: LEUNBACH IB
IPC: G01N24/10
Filed: 1988-06-22
Granted: 1991-05-30
Abstract: A magnetic resonance image generating apparatus (1) comprising a first radiation source (5,7,8) capable of emitting a first radiation of a frequency selected to excite nuclear spin transitions in selected nuclei in a sample (2) being imaged and means (7) for detecting free induction decay signals from said selected nuclei, characterised in that said apparatus further comprises a second radiation source (6,9,10) capable of emitting a second radiation of a frequency selected to excite electron spin transitions coupled to the nuclear spin transitions of at least some of said selected nuclei.
Patent AU-748344-B2 (AU)
Title: Process for production of wood composites using a mixed PMDI/solid novolac resin binder
Inventor: ROSTHAUSER JAMES W
IPC: C08G18/34
Filed: 1999-12-10
Granted: 2002-06-06
Abstract: This invention relates to a process for the production of composite wood products. This process comprises a) applying a binder composition to wood particles, and b) molding or compressing the wood particles treated with the binder to form a composite wood product. Suitable binder compositions comprise a polymethylene poly(phenyl isocyanate) and a solid novolac resin.
Patent AU-662918-B2 (AU)
Title: Valve arrangement
Inventor: AURELL ESKIL
IPC: F16K31/12
Filed: 1992-06-23
Granted: 1995-09-21
Abstract: PCT No. PCT/SE92/00453 Sec. 371 Date Feb. 10, 1994 Sec. 102(e) Date Feb. 10, 1994 PCT Filed Jun. 23, 1992 PCT Pub. No. WO93/01433 PCT Pub. Date Jan. 21, 1993.A valve arrangement includes a valve housing having a circular cylindrical portion in which is formed a valve chamber, a control valve and a valve member. The valve chamber has an inlet adapted to be connected to a pressure-medium source for allowing pressure-medium to flow into the valve chamber and an outlet through which pressure-medium flows out of the valve chamber. The control valve is movable between a closed position in which the outlet of the valve chamber is closed and an open position in which the outlet of the valve chamber is open. The valve member is freely displaceable within the circular cylindrical portion of the valve housing based on the pressure within the valve chamber. The valve member includes a piston which is movable between a closing position in which the piston is adapted to prevent the flow of pressure-medium and an opening position in which the piston is adapted to permit the flow of pressure-medium. The inlet of the valve chamber is defined by an annular gap formed between the piston and the circular cylindrical portion of the valve housing.
Patent AU-563973-B2 (AU)
Title: Imidazole and pyrazole derivatives to remove undesirable organic matter
Inventor: PETERSEN ARTHUR WALTER
IPC: C11D7/32
Filed: 1984-01-16
Granted: 1987-07-30
Abstract: A method of removing undesirable organic matter, such as food soil, paint, or the like, comprises contacting the organic matter with imidazole, pyrazole, an alkyl or aryl substituted imidazole, an alkyl or aryl substituted pyrarole, or a mixture of two or more thereof. Compositions containing these compounds as the active ingredient are also disclosed.
Patent AU-782648-B2 (AU)
Title: Use of 5HT3 agonists for relaxing the fundus
Inventor: MEULEMANS ANN LOUISE GABRIELLE
IPC: A61K31/47
Filed: 2000-11-20
Granted: 2005-08-18
Abstract: The present invention is concerned with the use of compounds having 5HT<SUB>3 </SUB>agonistic activity in conditions involving an impaired relaxation of the fundus, in particular dyspepsia.
Patent AU-655844-B2 (AU)
Title: Method for purifying nitric oxide-containing gas
Inventor: SOETE GERARD DE
IPC: B01D53/56
Filed: 1992-09-18
Granted: 1995-01-12
Abstract: PCT No. PCT/EP92/02173 Sec. 371 Date Jun. 22, 1994 Sec. 102(e) Date Jun. 22, 1994 PCT Filed Sep. 18, 1992 PCT Pub. No. WO93/06916 PCT Pub. Date Apr. 15, 1993.A process for purifying a gas containing nitrogen monoxide to remove nitrogen monoxide therefrom, includes adjusting oxygen content of the gas to provide a quantity of oxygen which is at least equal to a stoichiometric quantity which is necessary in order to oxidize the nitrogen monoxide contained in the gas to nitrogen dioxide; contacting the gas, substantially in the absence of any liquid, with an alkali metal pyrosulphite which is a solid and which is employed in a quantity which is sufficient to convert the nitrogen monoxide contained in the gas to alkali metal nitrite and alkali metal nitrate; and removing the alkali metal nitrite and the alkali metal nitrate from the gas.
Patent AU-773603-B2 (AU)
Title: Instrument and method for creating an intervertebral space for receiving an implant
Inventor: MICHELSON GARY K
IPC: A61F2/30
Filed: 2000-01-25
Granted: 2004-05-27
Abstract: A surgical instrument set for use in spinal surgery for forming a substantially quadrilateral space in the spine for implanting a spinal implant at least in part into and at least in part across a disc space between adjacent vertebral bodies and methods of use are disclosed. The instrument set includes an extended guard for providing protected access to the disc space and the adjacent surfaces of the adjacent vertebral bodies, a guide insertable into the guard, and a bone removal device insertable into said guide.
Patent AU-608401-B2 (AU)
Title: Ketenedithioacetal derivative and processes for producing the same as well as a composition containing the same
Inventor: NAGAMINE MASASHI
IPC: C07D285/00
Filed: 1989-01-11
Granted: 1991-03-28
Abstract: The ketenedithioacetal derivatives of formula (I) have a potent hypolipidemic and anit-arteriosclerotic effect and are useful for prophylaxis and treatment of arteriosclerosis or hyperlipidemia.
Patent AU-659238-B2 (AU)
Title: Oxidative hair coloring composition and process for dyeing human keratinous fibers
Inventor: PAN YUH-GOU
IPC: A61K8/34
Filed: 1992-11-25
Granted: 1995-05-11
Abstract: A single-stage process for dyeing keratinous fibers in intense colors comprising simultaneously applying to said keratinous fibers a composition comprising iodide ions, an oxidant and an effective concentration of an oxidation dye to produce said intense colors when the pH of said composition is alkaline. <IMAGE>
Patent AU-673506-B2 (AU)
Title: Inhibitors of cell regulatory factors and methods for preventing or reducing scarring
Inventor: RUOSLAHTI ERKKI I
IPC: C07K14/475
Filed: 1992-11-13
Granted: 1996-11-14
Abstract: The present invention provides a method of inhibiting an activity of a cell regulatory factor comprising contacting the cell regulatory factor with a purified polypeptide, wherein the polypeptide comprises the cell regulatory factor binding domain of a protein and wherein the protein is characterized by a leucine-rich repeat of about 24 amino acids. In a specific embodiment, the present invention relates to the ability of decorin, a 40,000 dalton protein that usually carries a glycosaminoglycan chain, to bind TGF- beta . The invention also provides a novel cell regulatory factor designated MRF. Also provided are methods of identifying, detecting and purifying cell regulatory factors and proteins which bind and affect the activity of cell regulatory factors. The present invention further relates to methods for the prevention or reduction of scarring by administering decorin or a functional equivalent of decorin to a wound. The methods are particularly useful for dermal wounds resulting from burns, injuries or surgery. In addition, the present invention includes pharmaceutical compositions containing decorin or its functional equivalent and a pharmaceutically acceptable carrier useful in such methods. Finally, methods for preventing or inhibiting pathological conditions by administering decorin are also provided. <IMAGE>   <IMAGE>
Patent AU-659264-B2 (AU)
Title: Acetabular cup for a total hip prosthesis and total hip prosthesis embodying such cups
Inventor: RUSHTON NEIL
IPC: A61F2/00
Filed: 1993-01-22
Granted: 1995-05-11
Abstract: An acetabular cup for a total hip prosthesis including an outer backing (10) and an inner bearing component (11), characterised in that said backing (10) comprises a part-spherical main portion (16) and two independent arms (17,18) projecting therefrom and which are separated from each other. <IMAGE>
Patent AU-701471-B2 (AU)
Title: Interleukin-1 antagonist
Inventor: MUZIO MARTA
IPC: A61K38/20
Filed: 1995-10-12
Granted: 1999-01-28
Abstract: It is described a new interleukin-1 antagonist active both against IL-1 alpha  and IL-1 beta , a new DNA sequence encoding the Il-1 antagonist and the method for obtaining a IL-1 antagonist by the recombinant DNA technique; it is also described the prophylactic, therapeutic and diagnostic use of such new IL-1 antagonist in pathologies deriving from the IL-1 production.
Patent AU-615560-B2 (AU)
Title: Frying-fat composition
Inventor: OOSTEN CORNELIS WILLEM VAN
IPC: A23L5/10
Filed: 1989-06-27
Granted: 1991-10-03
Abstract: The present invention is concerned with a frying fat composition essentially consisting of a mixture of one or more non-digestible polyol fatty acid polyesters and one or more glyceride fats, wherein the composition comprises of from 25% to 75% by weight of said polyesters, the blend of said polyesters having a slip melting point of between 35 and 50 DEG C, and the blend of said glyceride fats having a slip melting point of below 40 DEG C. The frying fat compositions according to the invention offers the advantage that, upon frying, deficiencies such as surface fattiness, poor drip-off and mildewing polyol fatty acid polyester are not observed. Another aspect of the present invention is the ue of a frying fat composition according to the invention for frying food products. Yet another aspect of the invention are fried food products that have been fried in a frying fat according to the invention.
Patent AU-663186-B2 (AU)
Title: High foaming nonionic surfactant based liquid detergent
Inventor: REPINEC STEPHEN T JR
IPC: C11D1/30
Filed: 1993-05-27
Granted: 1995-09-28
Abstract: A high foaming, nonionic surfactant based, light duty, liquid detergent with desirable cleansing properties and mildness to the human skin comprising three essential surfactants: a water soluble nonionic surfactant as the major active ingredient, in an amount in excess of 50% by weight of the total surfactant content; a supplemental amount of a water soluble, foaming, anionic surfactant excluding the ethoxylated alkyl ether sulfates; and 2.5 wt.% or less of a water soluble, foaming zwitterionic betaine surfactant.
Patent AU-715067-B2 (AU)
Title: A polynucleotide tuberculosis vaccine
Inventor: LIU MARGARET A
IPC: A61K39/04
Filed: 1995-11-13
Granted: 2000-01-13
Abstract: Genes encoding Mycobacterium tuberculosis (M.tb) proteins were cloned into eukaryotic expression vectors to express the encoded proteins in mammalian muscle cells in vivo. Animals were immunized by injection of these DNA constructs, termed polynucleotide vaccines or PNV, into their muscles. Immune antisera was produced against M.tb antigens. Specific T-cell responses were detected in spleen cells of vaccinated mice and the profile of cytokine secretion in response to antigen 85 was indicative of a Th1 type of helper T-cell response (i.e., high IL-2 and IFN-gamma). Protective efficacy of an M.tb DNA vaccine was demonstrated in mice after challenge with M.bovis BCG, as measured by a reduction in mycobacterial multiplication in the spleens and lungs of M.tb DNA-vaccinated mice compared to control DNA-vaccinated mice or primary infection in naive mice.